David Baker, the Nobel Prize-winning scientist known for protein design, is now using artificial intelligence to create molecules not found in nature, according to an interview with WIRED en Español. The work builds on his earlier achievements in protein engineering and shifts the focus from understanding natural structures to inventing entirely new biological ones.
In the interview, Baker discussed where biological design is heading next, emphasizing both the promise and the danger of taking biology beyond its natural limits. That dual message matters for business: AI-driven molecule design could open new product categories in medicine, materials, and other industries, but it also comes with questions about safety and oversight.
Because this is a single source, there are no competing viewpoints to compare. Even so, the conversation signals a broader trend: AI is becoming a central tool in biotech, not just for analyzing life as it exists, but for imagining and manufacturing what nature never made.